Bartlett & Co’s Definitive Healthcare DH Stock Holding History

Bartlett & Co’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-84	Closed	-$2K	–	1177
2022 Q2	$2K	Buy	+84	New	+$1.8K	﹤0.01%	1163

Other funds holding DH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

SEM

Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bartlett & Co's DH Position: Q3 2022 in Review

Bartlett & Co sold out of Definitive Healthcare (DH) in Q3 2022, closing a stake of 84 shares — an estimated $2K sold.

Bartlett & Co first reported a position in DH in Q2 2022 and held it in 1 quarter. The position peaked at $2K in Q2 2022. 123 funds tracked by Wall St. Rank hold DH as of Q3 2022.

Bartlett & Co reported no remaining Definitive Healthcare position as of Q3 2022 after selling out during the quarter.
Bartlett & Co sold 84 Definitive Healthcare shares in Q3 2022, an estimated $2K.
Bartlett & Co first reported a position in Definitive Healthcare in Q2 2022 and held it in 1 quarter.
Bartlett & Co's Definitive Healthcare position peaked at $2K in Q2 2022.
123 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2022.

Based on Bartlett & Co's 13F filing for Q3 2022, filed 17 Oct 2022.